BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study. [electronic resource]
Producer: 20031002Description: 1613-8 p. digitalISSN:- 0006-4971
- Acute Disease
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cytarabine -- administration & dosage
- Daunorubicin -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Genetic Markers
- Genetic Predisposition to Disease -- epidemiology
- Humans
- Karyotyping
- Leukemia, Myeloid -- epidemiology
- Male
- Middle Aged
- Multivariate Analysis
- Neoplasm Proteins -- genetics
- Predictive Value of Tests
- Prognosis
- Reverse Transcriptase Polymerase Chain Reaction
- Risk Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.